接受即刻乳房再造的阿片类药物初治女性的处方阿片类药物使用
基于Truven Health MarketScan数据库纳入2010年1月至2014年8月4113例阿片类药物初治的乳房切除即刻乳房再造患者,90%围手术期有阿片类药物处方取药,10%在术后3个月后继续取药;抑郁与更高日均口服吗啡当量相关,焦虑与长期取药相关,自体游离皮瓣再造者长期取药比例更低。
要点
- 4113例阿片初治即刻乳房再造患者中,90%围手术期取阿片处方,10%术后3个月后仍取药。
- 抑郁患者日均口服吗啡当量更高(74.2 mg vs 58.3 mg,p < 0.01)。
- 焦虑患者长期取药比例更高(13.4% vs 9.1%,p < 0.01);自体游离皮瓣再造者长期取药更低(5.9% vs 10.2%,p < 0.001)。
核心结论
- 乳房再造后处方阿片类药物取药常见,10%的患者在术后3个月后继续取阿片类药物处方。
- 长期取药受患者因素和手术方式影响,应尽可能识别阿片类药物替代方案。
研究设计与样本
- 利用Truven Health MarketScan Research Databases识别2010年1月至2014年8月间4113例接受乳房切除和即刻乳房再造的阿片类药物初治患者队列。
- 采用多变量回归分析患者人口学特征、再造技术、共病医学与精神疾病及术后并发症对结局变量的影响。
主要发现
- 该队列中90%的患者围手术期有阿片类药物处方取药,10%在术后3个月后继续取药。
- 抑郁患者更可能取更高日均口服吗啡当量的处方(74.2 mg vs 58.3 mg;p < 0.01)。
- 焦虑患者更可能长期取阿片类药物(13.4% vs 9.1%;p < 0.01)。
- 接受自体游离皮瓣再造的患者术后长期取药可能性更低(5.9% vs 10.2%;p < 0.001)。
临床怎么用
- 作者认为应尽可能识别阿片类药物替代方案。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cancer patients may be particularly vulnerable to the deleterious effects of prolonged opioid use. The authors explored the factors that influence postoperative opioid prescription fills among women following postmastectomy reconstruction. METHODS: Using the Truven Health MarketScan Research Databases, the authors identified a cohort of 4113 opioid-naive patients undergoing mastectomy and immediate breast reconstruction between January of 2010 and August of 2014. Outcomes included average daily oral morphine equivalents and the incidence of prolonged opioid fills (between 90 and 120 days after surgery). Using multivariable regression, the authors examined the effect of patient demographic characteristics, reconstructive technique, comorbid medical and psychiatric conditions, and postoperative complications on outcome variables. RESULTS: In this cohort, 90 percent of patients filled opioid prescriptions perioperatively, and 10 percent continued to fill prescriptions beyond 3 months after surgery. Patients with depression were more likely to fill prescriptions of higher average daily oral morphine equivalents (74.2 mg versus 58.3 mg; p < 0.01), and patients with anxiety were more likely to fill opioids for prolonged periods (13.4 percent versus 9.1 percent; p < 0.01). Patients undergoing autologous free flap reconstruction were less likely to fill prescriptions for a prolonged period following surgery (5.9 percent versus 10.2 percent; p < 0.001). CONCLUSIONS: Prescription opioid fills are common following breast reconstruction, and 10 percent of all patients continue to fill opioid prescriptions beyond 3 months after surgery. Prolonged fills are influenced by both patient factors and surgical procedure, and attention should be directed toward identifying opioid alternatives when possible. CLINCAL QUESTION/LEVEL OF EVIDENCE: Risk, III.
引用
- Marcusa DP, Mann RA, Cron DC, et al. Prescription Opioid Use among Opioid-Naive Women Undergoing Immediate Breast Reconstruction. Plast Reconstr Surg. 2017. PMID: 29176408. doi:10.1097/PRS.0000000000003832
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。